Norges Bank Makes New $103.30 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Norges Bank acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,492,793 shares of the company's stock, valued at approximately $103,301,000. Norges Bank owned about 1.20% of Henry Schein as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the company. Olstein Capital Management L.P. boosted its stake in shares of Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after purchasing an additional 16,000 shares in the last quarter. Private Management Group Inc. lifted its holdings in Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after buying an additional 18,882 shares during the period. Equitable Trust Co. bought a new stake in Henry Schein in the fourth quarter valued at $417,000. Savant Capital LLC increased its position in shares of Henry Schein by 43.9% during the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock valued at $322,000 after buying an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock worth $1,113,000 after acquiring an additional 3,650 shares during the period. Institutional investors own 96.62% of the company's stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Finally, Barrington Research restated an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $81.10.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Price Performance

HSIC stock traded down $1.12 during mid-day trading on Friday, hitting $65.47. The company had a trading volume of 2,362,489 shares, compared to its average volume of 1,585,938. The company has a 50-day moving average price of $73.96 and a 200 day moving average price of $72.58. Henry Schein, Inc. has a 12-month low of $63.00 and a 12-month high of $82.49. The company has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the company posted $0.66 earnings per share. Henry Schein's quarterly revenue was up 5.8% on a year-over-year basis. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.